Welcome to our dedicated page for Materialise SEC filings (Ticker: MTLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Materialise NV files as a foreign private issuer, and its SEC reports document financial results, capital actions, and corporate disclosures for its additive manufacturing software, medical, and manufacturing businesses. Form 6-K reports include quarterly result releases, segment revenue for Materialise Medical, Materialise Software, and Materialise Manufacturing, expense categories such as R&D, sales and marketing, and general and administrative costs, cash balances, and exhibits incorporated by reference into a Form F-3 registration statement.
The company’s filings also cover Belgian-law annual report materials, share buyback program updates, treasury-share holdings, exchange execution details, and share-capital disclosures tied to its Nasdaq ADSs and Euronext-listed ordinary shares.
Materialise NV reported stable revenue but a clear profitability improvement in the first quarter of 2026. Total revenue was 66,276 kEUR, essentially flat versus 66,379 kEUR a year earlier, but gross margin rose to 57.2% from 55.3%.
Net profit improved to 1,820 kEUR, compared to a net loss of 535 kEUR in 2025, helped by a stronger net financial result and higher gross profit. Adjusted EBITDA increased to 8,049 kEUR from 6,147 kEUR, lifting the Adjusted EBIT margin to 3.7% from 1.0%.
The Materialise Medical segment grew revenue 6.7% to 33,165 kEUR, while Software dipped 1.4% and Manufacturing fell 8.1%. All three segments showed higher Adjusted EBITDA, with Manufacturing moving from a loss to a small profit. The company ended March 31, 2026 with 132,952 kEUR in cash and a net cash position of 72,826 kEUR and had repurchased 511,513 shares for 2,308 kEUR. After quarter-end, Materialise agreed to transfer its eyewear business to its management team and expects to record impairment charges in the second quarter of 2026.
Materialise NV reported first quarter 2026 revenue of 66,276 kEUR, essentially flat year over year, but turned to a net profit of 1,820 kEUR from a loss of 535 kEUR. Adjusted EBIT rose to 2,470 kEUR, a 3.7% margin versus 1.0% a year earlier, and Adjusted EBITDA increased to 8,049 kEUR.
Medical revenue grew 6.7% to 33,165 kEUR, while Software declined slightly and Manufacturing fell 8.1%, though both segments improved profitability. Gross margin expanded to 57.2%. The company ended the quarter with 132,952 kEUR in cash, a 72,826 kEUR net cash position, and positive free cash flow.
Materialise agreed to transfer its eyewear business to its management team, retaining a minority stake and expecting impairment charges in the second quarter of 2026. Despite the Rapidfit and Eyewear divestments, the company reaffirmed its 2026 revenue guidance of 273,000–283,000 kEUR and Adjusted EBIT guidance of 10,000–12,000 kEUR.
Materialise NV reports progress on its ongoing share buy-back program. During 27 April to 1 May 2026, the company repurchased 27,493 shares at an average price of 4.54 EUR per share, for a total of 124,826 EUR.
Since the program started on 26 January 2026, Materialise has bought back 629,080 shares for 2,832,788 EUR (3,335,311 USD), equal to 1.1% of its total shares outstanding. The company currently holds these 629,080 shares and may continue repurchases under its mandate of up to 30 million EUR.
Materialise NV reports progress on its ongoing share buy-back program of up to EUR 30 million. Between 20 and 24 April 2026, the company repurchased 25,004 shares on Nasdaq at an average price of EUR 4.56, for a total of EUR 114,106.
Since the program began on 26 January 2026, Materialise has bought back 601,587 shares for EUR 2,707,962 (about USD 3,189,210), equal to 1% of total shares outstanding. The company now holds these 601,587 shares as its own stock and plans to keep updating buy-back data weekly on its investor website.
Materialise NV, a Belgium-based 3D printing and software company, files its annual report outlining how it runs and grows its additive manufacturing business across software, medical and manufacturing segments. The report emphasizes dependence on broader adoption of 3D printing, the shift from on-premise licenses to cloud and SaaS platforms, and heavy exposure to automotive, aerospace and orthopedic markets, which together drive 40% of annual turnover.
Materialise highlights reliance on collaborations with major medical device companies, substantial ongoing R&D and AI/ML investments, and intensifying competition as barriers to entry fall. It details operational and cybersecurity risks as it moves more products to cloud delivery, and notes that only 2.3% of revenue is generated in Belgium while international operations, including more than 400 staff in Kyiv, Ukraine, expose it to geopolitical and macroeconomic shocks. The company also underscores regulatory complexity in its medical segment, including EU Medical Device Regulation, FDA rules, GDPR, HIPAA and emerging AI and ESG requirements, any of which could increase costs or restrict growth.
Materialise NV reports progress on its ongoing share buy-back program of up to EUR 30 million. Between 13 and 17 April 2026, the company repurchased 31,054 shares at an average price of EUR 4.45, for a total of EUR 138,089, via Nasdaq.
Since the program began on 26 January 2026, Materialise has bought back 576,583 shares for EUR 2,593,856 (USD 3,055,313), equal to about 1% of total shares outstanding. All repurchases were executed through the central order book, with no cross or block trades.
Materialise NV reports progress on its previously announced share buy-back program of up to EUR 30 million. Between 6 and 10 April 2026, the company repurchased 24,690 shares at an average price of 4.32 EUR, for a total of 106,768 EUR (124,267 USD).
Since the program began on 26 January 2026, Materialise has bought back 545,529 shares for 2,455,767 EUR (2,893,063 USD), representing 0.9% of its total shares outstanding, which it now holds as treasury shares.
Materialise NV reports progress on its ongoing share buyback program. Between 30 March 2026 and 3 April 2026, the company repurchased 21,361 shares at an average price of 4.29 EUR, for a total of 91,712 EUR, via Nasdaq.
Under the program, Materialise can buy back up to EUR 30 million of its shares through an independent financial intermediary. Since the program began on 26 January 2026, it has repurchased 520,839 shares for 2,349,000 EUR (2,768,796 USD), equal to 0.9% of total shares outstanding, which it now holds as treasury shares.
Materialise NV reports progress on its ongoing share buy-back program of up to EUR 30 million. During the week from 23 to 27 March 2026, the company repurchased 50,994 shares at an average price of 4.26 EUR per share, for a total of 217,478 EUR.
All purchases were executed on Nasdaq through the central order book, with no cross or block trades. Since the program started on 26 January 2026, Materialise has bought back 499,478 shares for 2,257,288 EUR (2,663,137 USD), equal to 0.8% of its total shares outstanding, and now holds these shares in treasury.